View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore granted a restricted stock unit (“RSU”) award with respect to 45,000 shares of its common stock, an option for 210,000 shares of stock, an RSU for 170,000 shares of common stock, and a performance stock unit (“PSU”) award for up to 370,000 shares of its common stock to Thomas D. Salus, Lifecore’s newly hi...

Dan Salmon
  • Dan Salmon

Meta Platforms (META, Buy, $775 target) Reddit (RDDT, Neutral, $180 ta...

RDDT recently made a change to the Reddit Ads platform to allow advertisers to import campaign details directly from Meta Ads Manager. For RDDT, the benefit is obvious: it’s now much easier for META’s millions of advertisers to launch RDDT ad campaigns, which should accelerate growth of RDDT’s small and medium-sized (SMB) advertiser base and could do so materially. However, we think there are implications for META too, especially as the FTC’s antitrust case seeking the divestment of Instagram a...

 PRESS RELEASE

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Admini...

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate Governance, Transactional Activities, and SEC Reporting and Compliance CHASKA, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has appointed Th...

Dan Salmon
  • Dan Salmon

Meta Platforms (META, Buy, $775 target) Ad recession outperformer? Lo...

In the past few weeks, META has shared more details on its latest innovations “under the hood” in the ad system, including the new Generative Ads Recommendation Model (GEM).

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch